CONFORMIS INC. overview

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Conformis, Inc. (NasdaqCM: CFMS) to restor3d, Inc. Under the terms of the proposed transaction, shareholders of Conformis will receive $2.27 in cash for each share of Conformis that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the...

Shareholder Alert: Ademi LLP investigates whether Conformis, Inc. has obtained a Fair Price in its transaction with restor3d PR Newswire MILWAUKEE, June 23, 2023 MILWAUKEE , June 23, 2023 /PRNewswire/ -- Ademi LLP is investigating Conformis (NASDAQ: CFMS) for possible breaches of fiduciary duty and other violations of law in its transaction with restor3d . Click here to learn how to join the action https://www.ademilaw.com/case/conformis-inc or call Guri Ademi toll-free at 866-264-3995. There is...

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Conformis, Inc. (NASDAQ: CFMS) to restor3d for $2.27 per share in cash is fair to Conformis shareholders. Halper Sadeh encourages Conformis shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected] . The investigation concerns whether Conformis and its board of directors violated the...

Thinking about buying stock in Veoneer, Abeona Therapeutics, ConforMIS, Neurobo Pharmaceuticals, or Acutus Medical? PR Newswire NEW YORK, July 23, 2021 NEW YORK , July 23, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for VNE, ABEO, CFMS, NRBO, and AFIB. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. VNE:...

...